AnaptysBio, Inc. ANAB Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s investment proceeds?
- AnaptysBio, Inc. (ANAB) reported investment proceeds of $35M in Q1 2026.
- How has AnaptysBio, Inc.'s investment proceeds changed year-over-year?
- AnaptysBio, Inc.'s investment proceeds decreased by 74.5% year-over-year, from $137.43M to $35M.
- What is the long-term trend for AnaptysBio, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s investment proceeds has grown at a 27.9% compound annual growth rate (CAGR), from $158.85M to $424.53M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.